Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
660 Leser
Artikel bewerten:
(1)

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival ...

NEW YORK" March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.'s securities were suspended on August 10, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals, Inc.'s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Collective Audience, Inc. Collective Audience, Inc.'s warrants were suspended on November 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of SeqLL Inc. SeqLL Inc.'s securities were suspended on November 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Nemaura Medical Inc. Nemaura Medical Inc.'s securities were suspended on January 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of LumiraDx Limited. LumiraDx Limited's securities were suspended on January 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Series 1 Preferred Stock of Cemtrex Inc. Cemtrex Inc.'s shares of Series 1 Preferred Stock were suspended on January 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the perpetual preferred stock, common stock, and warrants of COMSovereign Holding Corp. COMSovereign Holding Corp.'s shares of perpetual preferred stock were suspended on January 23, 2024; the company's shares of common stock and warrants were suspended on January 31, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Global System Dynamics. Global System Dynamics's securities were suspended on January 24, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Arrival. Arrival's securities were suspended on January 30, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrant of Nubia Brand International Corp. Nubia Brand International Corp.'s securities were suspended on February 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of The Alkaline Water Company Inc. The Alkaline Water Company Inc.'s securities were suspended on February 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DMK Pharmaceuticals Corporation. DMK Pharmaceuticals Corporation's securities were suspended on February 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of MedAvail Holdings, Inc. MedAvail Holdings, Inc.'s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.'s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ADDvantage Technologies Group, Inc. ADDvantage Technologies Group, Inc.'s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2024 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.